uridine monophosphate has been researched along with Liver Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lazarus, JV; Lens, S | 1 |
| Keegan-Rogers, V; Wu, GY | 1 |
2 other study(ies) available for uridine monophosphate and Liver Dysfunction
| Article | Year |
|---|---|
The paediatric population: the forgotten element to eliminating hepatitis C virus.
Topics: Adolescent; Antiviral Agents; Benzimidazoles; Child; Chronic Disease; Drug Therapy, Combination; Female; Fluorenes; Hepacivirus; Hepatitis C; Humans; Infectious Disease Transmission, Vertical; Liver Diseases; Male; Prevalence; Risk Factors; Sofosbuvir; Uridine Monophosphate; Young Adult | 2020 |
Targeted protection of hepatocytes from galactosamine toxicity in vivo.
Topics: alpha-Fetoproteins; Animals; Asialoglycoprotein Receptor; Asialoglycoproteins; Behavior, Animal; Chemical and Drug Induced Liver Injury; Female; Fetuins; Galactosamine; Injections, Intravenous; Iodine Radioisotopes; Liver; Liver Diseases; Polylysine; Rats; Rats, Inbred Strains; Receptors, Immunologic; Uridine Monophosphate | 1990 |